Research into Alzheimer’s disease is making progress, but big challenges remain. The proposed project, AD-SMART, is a quicker, more efficient way of identifying effective treatments for Alzheimer’s. The trial will be for a period of about four years. It will test whether either of two existing medicines (atomoxetine and immediate-release (IR) metformin) can relieve and improve symptoms in patients with Alzheimer’s. Currently, they are used for other illnesses and are known to be safe and effective for those diseases. It will also assess each treatment’s side effects (if any), whether they improve quality of life, and offer the health service sufficient value for money.

To learn more about AD-SMART, please click here.